Back to list2026 H1

Kenta Tanaka

Grade G4Lead Associate ・ Pharma Knowledge SupportIn reviewDivergence

Evidence composite 3.6↔Supervisor 4.8Supervisor more generous than evidence by +1.2

Value radar

EvidenceSupervisorDept avg

Activity metrics

Messages

412

Docs edited

Meetings

Avg response

4.2h

Cross-team reach

5 teams

Peer support

Initiative

Facilitation

12%

Evidence points

144

Values

Key conversationsCollaboration1

Joint proposal project

Period 6/3–6/12

− Counter-evidence

Spanned solo doc editing, a missed cross-dept sync, and a late Slack follow-up.

Timeline

6/3Edited the joint proposal solo; only 2 review comments left for othersInformation sharing
6/8Attended 38% of the cross-department syncs for the proposalCollaboration
6/12Posted a late status update after the deadline had passedPeer support

Impact on work

Proposal skewed to solo work; review feedback lagged and final sign-off slipped 2 days.

Bias / divergence check

Integrity

Supervisor

4.8

Evidence est.

3.2

+1.6

Expertise

Supervisor

4.8

Evidence est.

4.6

+0.2

Collaboration

Supervisor

4.8

Evidence est.

2.9

+1.9

Initiative

Supervisor

4.8

Evidence est.

4.4

+0.4

Customer focus

Supervisor

4.8

Evidence est.

4.1

+0.7

The evaluation skews toward results-oriented values (Expertise). We recommend re-checking the evidence for behavioral values (Collaboration, Integrity).